TRIUMPH-1 (80 Weeks) The pivotal TRIUMPH-1 obesity trial (2,339 adults, no diabetes), presented at ADA 2026, extended the treatment window to 80 weeks and produced the largest pivotal weight-loss readout to date: Among the 12 mg group, 45.3% lost at least 30% of their body weight and 65.3% ended the trial with a BMI below 30
I started hiking with my kids on weekends because I wanted to, not because I felt obligated
Once youve achieved your weight loss goal, our specialists will work with you to decrease your medication dosage if able
A Type II DMF for a complex API with an approved NDA or ANDA reference has calculable value: it represents years of process development work (typically three to seven years for a complex molecule), cost of analytical method development and validation, stability study datasets (ICH Q1A long-term, intermediate, and accelerated conditions), and the regulatory relationship capital embedded in any prior FDA communications or deficiency responses
They work by stimulating your bodys natural GH production rather than providing exogenous hormone directly